An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Walgreens Boots Alliance Appoints Steven J. Shulman to Its Board of Directors
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Walgreens Boots Alliance (WBA) announced the appointment of Steven J. Shulman to its board of directors, effective January 27, 2022. Bringing a wealth of healthcare management experience and an extensive background in emerging healthcare technologies, Shulman is expected to provide valuable insights as WBA continues to enhance local healthcare delivery. His previous leadership roles include CEO of Magellan Health Services. Executive Chairman Stefano Pessina and CEO Roz Brewer expressed confidence in Shulman's contributions towards the company’s consumer-centric healthcare strategy.
Positive
Shulman's extensive healthcare management experience and leadership in emerging technologies.
Expected to provide valuable insights into local healthcare delivery.
Shulman’s previous roles could strengthen WBA’s position in community healthcare.
Negative
None.
Brings deepleadership expertise in healthcare, along with significant private sector experience
DEERFIELD, Ill.--(BUSINESS WIRE)--
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Steven J. Shulman to the company’s board of directors. He joins the board as a director, effective Jan. 27, 2022, and becomes the board’s eleventh member.
Steven J. Shulman joins WBA Board of Directors (Photo: Business Wire)
Shulman brings a wealth of healthcare management experience, as well as an extensive leadership background in emerging healthcare technologies. He currently serves on the boards at both VillageMD and CareCentrix, two companies in which WBA has recently taken a majority ownership interest. Shulman will provide valuable insights and unique perspective to the WBA board as the company accelerates efforts to reimagine local healthcare delivery.
“Steven is a tremendous addition to our board of directors. His vast leadership experience and in-depth knowledge across the healthcare spectrum will be invaluable as we move into our next phase of being a market leader at the center of community healthcare,” said Stefano Pessina, Executive Chairman, Walgreens Boots Alliance.
“We are very pleased to welcome Steven to our board,” said Roz Brewer, Chief Executive Officer, Walgreens Boots Alliance. “We look forward to benefiting from his industry expertise and viewpoints on the evolving healthcare landscape, as we continue to execute our consumer-centric healthcare strategy and drive long-term shareholder value.”
Shulman currently serves as the Chairman of CareCentrix, Inc. and SOC Telemed; he also serves as co-Chairman of HealthMap Solutions and as Lead Director of VillageMD. He is a director of several other privately held companies, including Facet Technologies, Ensemble Healthcare Partners and Pager, Inc. Shulman is also Managing Partner at Shulman Family Ventures, Inc., a private equity firm.
His prior healthcare leadership experience includes roles as Chairman and Chief Executive Officer of Magellan Health Services, Inc. He previously served as Chairman and Chief Executive Officer of Internet Healthcare Group, LLC and as Chairman, President and Chief Executive Officer of Prudential Healthcare, where he was also Director and President of the Pharmacy and Disease Management Group. Shulman held senior positions at Cigna Corporation, including President of the East Central Division, and Kaiser Permanente, including Director, Medical Economics. He served as Chairman of the Board of Directors of R1 RCM, Inc. and Health Management Associates, Inc.
“I am honored to join the Walgreens Boots Alliance board at an exciting and pivotal time, and look forward to working with the board and leadership team to further the great momentum they’ve built,” Shulman said. “I am confident WBA will make an even greater impact in the communities it serves, by improving access and health outcomes, while lowering the total cost of care.”
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.
A trusted, global innovator in retail pharmacy with approximately 13,000 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.
WBA has more than 315,000 team members and a presence in nine countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.
The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been recognized for its commitment to operating sustainably: it is an index component of the Dow Jones Sustainability Indices (DJSI) and was named to the 100 Best Corporate Citizens 2021.
